Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
2348 On Other Exchanges
Symbol
Exchange
2348 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kei Ling Li

Co-Founder, Chairman, Chief Executive Officer, Chairman of Nomination Committee and Member of Remuneration Committee, Dawnrays Pharmaceutical Holdings Ltd.
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 1 different industries.

See Board Relationships
65CNY922,000
As of Fiscal Year 2014

Background*

Ms. Kei Ling Li is Co-Founder of Dawnrays Pharmaceutical Holdings Ltd. and has been its Chief Executive Officer since March 1, 2015. Ms. Li served as Head of Corporate Development at Dawnrays Pharmaceutical Holdings Ltd. since March 1, 2015. She is responsible for the overall planning and implementation of corporate development, financial management and strategies formulation of the Dawnrays Pharmaceutical. Ms. Li has over 20 years of experience in corporate management ...

Read Full Background

Corporate Headquarters*

CNT Tower
Wanchai, -- --

Hong Kong

Phone: --
Fax: --

Board Members Memberships*

2002-Present
Co-Founder, Chairman, Chief Executive Officer, Chairman of Nomination Committee and Member of Remuneration Committee

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

SalaryCNY867,000
Total Annual CompensationCNY867,000

Stock Options*

All Other CompensationCNY17,000

Total Compensation*

Total Annual Cash CompensationCNY922,000
Total Short Term CompensationCNY867,000
Other Long Term CompensationCNY17,000
Total Calculated CompensationCNY922,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2348:HK $7.17 HKD +0.24

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAWNRAYS PHARMACEUTICAL HOLD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.